Companies: 10,795·Total market cap: $144.5T

IceCure Medical Ltd

IceCure Medical Ltd

ICCMNASDAQHealthcare● Active

$3.64

$-0.73(-16.70%)

Market Cap$8197473

P/E Ratio—

52W High$42

52W Low$3.62

Avg Volume35K

Open$4.40

Beta1.49

股票排行：Medical - Devices·Healthcare·查看全部市值排行 →

IceCure Medical Ltd（ICCM）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ICCM · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-6.98Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$3.6MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding2.1MShares outstanding history

Next EarningsAug 12, 2026Est.Earnings history

探索 IceCure Medical Ltd 数据

分析师预测$1 · Buy

股息不分红

营收$3.4M+2.67%

盈利EPS $-7.20+20.00%

财务快照

FY 2025Revenue$3.4M▲ +2.67% YoY

202320242025

FY 2025Net Income-$15.1M▲ +1.70% YoY

202320242025

FY 2025EPS$-7.20▲ +20.00% YoY

202320242025

TTM:Revenue: $3.6MNet Income: -$15.7MEPS: $-6.98View income statement →

分析师评级与目标价

Buy3 位分析师

Strong Buy

0

Buy

3

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$1.00Low

$3.64Current

$1.00Avg Target下行风险 72.53%

$1.00High

合计: 3 · 买入占比: 100.0%

根据过去 3 个月内 3 位华尔街分析师，ICCM 共识评级为 Buy，12 个月平均目标价 $1.00 （较现价 $3.64 下行风险 72.53%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

IceCure Medical Ltd

$3.64-16.70%$8.2M #2

Baird Medical Investment Holdings Limited

$1.28+1.59%$52.5M #3

Cytosorbents Corporation

$0.41-9.76%$26.0M #4

electroCore, Inc.

$9.64+10.55%$80.0M #5

Spectral AI, Inc.

$1.85-2.12%$58.9M #6

Medicus Pharma Ltd. Common Stock

$0.34-3.94%$7.4M

股票表现

1D-16.70%

1W-6.67%

1M-49.44%

3M-80.74%

YTD-80.11%

1Y-88.33%

5Y-98.89%

关于 IceCure Medical Ltd

CEOEyal Shamir

IPO DateAug 26, 2021

Employees64

CountryIL

Websiteicecure-medical.com

IceCure Medical Ltd Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumor…

Medical - Devices HealthcareNASDAQIL

关于股票概览与关键数据

IceCure Medical Ltd（ICCM）是 Medical - Devices 行业的 Healthcare 类公司，于 Aug 26, 2021 在 NASDAQ 上市。截至最近交易日，ICCM 股价为 $3.64，市值约为 $8.2M。过去12个月累计回报 -88.33%，年初至今回报 -80.11%。

根据 3 位华尔街分析师，IceCure Medical Ltd 股票共识评级为Buy，12个月平均目标价为 $1.00。2025 财年 IceCure Medical Ltd 营收 $3.4M，净利润 -$15.1M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，IceCure Medical Ltd（ICCM）股价为 $3.64，在 NASDAQ 上市，52周区间为 $3.62 – $42.00。

ICCM 最新股价ICCM quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议